Oncolytic Adenovirus-Loaded Menstrual Blood Stem Cells Overcome the Blockade of Viral Activity Exerted by Ovarian Cancer Ascites - Test2 - elhamkhani - TriplyDB

Oncolytic Adenovirus-Loaded Menstrual Blood Stem Cells Overcome the Blockade of Viral Activity Exerted by Ovarian Cancer Ascites

Oncolytic Adenovirus-Loaded Menstrual Blood Stem Cells Overcome the Blockade of Viral Activity Exerted by Ovarian Cancer Ascites

http://www.wikidata.org/entity/Q33904378

about

Human menstrual blood-derived stem cells promote functional recovery in a rat spinal cord hemisection model

P2860

Q57166869-E786DF6E-8299-4438-84DB-FA78E34B3CA8

P2860

Oncolytic Adenovirus-Loaded Menstrual Blood Stem Cells Overcome the Blockade of Viral Activity Exerted by Ovarian Cancer Ascites

http://www.wikidata.org/entity/Q33904378

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Oncolytic Adenovirus-Loaded Me ...... rted by Ovarian Cancer Ascites

@ast

Oncolytic Adenovirus-Loaded Me ...... rted by Ovarian Cancer Ascites

@en

type

label

Oncolytic Adenovirus-Loaded Me ...... rted by Ovarian Cancer Ascites

@ast

Oncolytic Adenovirus-Loaded Me ...... rted by Ovarian Cancer Ascites

@en

prefLabel

Oncolytic Adenovirus-Loaded Me ...... rted by Ovarian Cancer Ascites

@ast

Oncolytic Adenovirus-Loaded Me ...... rted by Ovarian Cancer Ascites

@en

P1433

Q33904378-7BB8ABC2-7261-4A2B-A686-1B2CF0E5A80C

P1476

Q33904378-A3AD16BA-C012-4230-88E4-F5BF89724A1C

P2093

Q33904378-13F850FE-077E-4EB3-9E34-2CA189E6A6D9

Q33904378-1CA07971-775F-480B-A345-71768D3B7C81

Q33904378-74218867-7F6A-49C7-8F3D-CBCDBEF172DD

Q33904378-7E5F7382-04AF-4AC5-8D54-4EF6E5B2B811

Q33904378-836B4AC1-11E1-4E9E-ABE7-05A4A27695F8

Q33904378-89537FD1-4F6D-4C95-A248-CE4FDE1EDF19

Q33904378-DA9C6126-63D6-4FB0-B014-FA1303E1B640

Q33904378-E6986C15-941C-4ACA-B35D-FFB54A8C4B34

Q33904378-F3A4814D-7F3A-430D-B14A-39FBE8E3B2D2

P2860

Q33904378-0056955C-1977-4587-B099-A5EF45D82FBF

Q33904378-04408B85-200B-4304-8819-12D0E257EE6C

Q33904378-1BE0A0CA-14E7-4487-ADB7-F74949F022AF

Q33904378-1E309BE3-8EB5-410B-BD82-89FA7D037B3E

Q33904378-308CFD2B-1906-4A37-B170-A14FB92FE6B8

Q33904378-4A53EF4F-828B-4732-BE47-F67A7FFF5E0F

Q33904378-51BF4ECD-5ADB-4151-AEB2-8F2CCBFBEFF3

Q33904378-57EF3E41-5EB6-42FA-89C0-A42E2569F498

Q33904378-74DCC020-6407-4F42-822C-95E595CE3860

Q33904378-77D64968-E0E2-454D-9F65-B7557164E120

P304

Q33904378-C75D48A9-8242-46B5-B06B-7BB0360DAA62

P31

Q33904378-06CA3FDF-DA31-4C9A-B5FD-37B5C922C4E6

P356

Q33904378-094CFAC3-F365-457B-9C96-CA9F7F361271

P478

Q33904378-0229FC39-2C21-4963-96EF-7294C01DA58D

P577

Q33904378-BED1BE06-0FB5-4606-A6C1-8CF5540BB852

P698

Q33904378-9BB72959-3136-4125-B224-A4953A0EE5C8

P921

Q33904378-549EF37A-AAE6-47E3-9DC3-9E1336AAC971

Q33904378-6E3CF9D7-183A-470F-BC7B-B512696278A2

Q33904378-AB301ECF-08C0-4D9E-A5E8-76C7F6946621

P932

Q33904378-6E76CE5E-6486-459A-B50E-3A3B5C6AEAED

P356

J.OMTO.2017.06.002

P1433

Molecular therapy oncolytics

P1476

Oncolytic Adenovirus-Loaded Me ...... rted by Ovarian Cancer Ascites

@en

P2093

Alejandro Nicola Candia

http://www.w3.org/2001/XMLSchema#string

Alejandro Soderini

http://www.w3.org/2001/XMLSchema#string

Ana Laura Alfano

http://www.w3.org/2001/XMLSchema#string

Cecilia Rotondaro

http://www.w3.org/2001/XMLSchema#string

Leandro N Guttlein

http://www.w3.org/2001/XMLSchema#string

Leonardo Sganga

http://www.w3.org/2001/XMLSchema#string

M Veronica Lopez

http://www.w3.org/2001/XMLSchema#string

Nicasio Cuneo

http://www.w3.org/2001/XMLSchema#string

Osvaldo L Podhajcer

http://www.w3.org/2001/XMLSchema#string

P2860

CellProfiler: image analysis software for identifying and quantifying cell phenotypes

Oncolytic virus therapy: A new era of cancer treatment at dawn

Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity

Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic

Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients.

Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells

Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironment

P304

31-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OMTO.2017.06.002

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28736743

http://www.w3.org/2001/XMLSchema#string

P921

Amzerioù (merc'hed)

oncolytic virus

P932

5510493

http://www.w3.org/2001/XMLSchema#string